lu 135252 has been researched along with Aging in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amann, K; Barton, M; Brandes, RP; Kretzler, M; Lange, M; Lattmann, T; Münter, K; Ortmann, J; Parekh, N; Traupe, T | 1 |
| Barton, M; Baumann, K; Haas, E; Hofmann-Lehmann, R; Münter, K; Ortmann, J; Parekh, N; Traupe, T | 1 |
2 other study(ies) available for lu 135252 and Aging
| Article | Year |
|---|---|
Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
Topics: Aging; Animals; Apoptosis; Blood Pressure; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; DNA; Endothelin A Receptor Antagonists; Endothelin-1; Gene Expression; Gene Silencing; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Kidney; Kidney Glomerulus; Male; Matrix Metalloproteinase 9; Phenylpropionates; Proteinuria; Pyrimidines; Rats; Rats, Wistar; Receptor, Endothelin A; Signal Transduction | 2004 |
Endothelin ETA receptor blockade with darusentan increases sodium and potassium excretion in aging rats.
Topics: Aging; Aldosterone; Animals; Chlorides; Endothelin A Receptor Antagonists; Endothelin-1; Male; Nitric Oxide; Phenylpropionates; Potassium; Pyrimidines; Rats; Rats, Wistar; Renin; Sodium; Sodium-Potassium-Exchanging ATPase | 2006 |